Global Systemic Lupus Erythematosus (SLE) Drugs Market 2015-2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Systemic Lupus Erythematosus (SLE) Drugs
Market 2015-2019
2
Description
Report Overview
SLE is the most common form of lupus and is also
called lupus. It is a chronic, autoimmune disease
with signs and symptoms that can last for six
months or for many years. It can affect any part
of the body, such as the skin, joints, and organs
(LFA, 2012). SLE occurs when the immune system
produces autoantibodies, which attack and destroy
healthy tissues in the body rather than foreign
infectious agents. These autoantibodies cause
inflammation, pain, and damage. It is also known
as a disease of flare-ups and remissions and can
range from mild to life threatening in severity.
No cure for SLE yet exists. Read more details
at http//www.bigmarketresearch.com/global-system
ic-lupus-erythematosus-sle-drugs-2015-2019-market
Analysts forecast the Global SLE Drugs market
to grow at a CAGR of 22.41 percent over the
period 2014-2019.
_at_Bigmarketresearch
3
Description
Report Overview
This report covers the present scenario and the
growth prospects of the Global SLE Drugs market
for the period 2015-2019. To calculate the market
size, the report considers revenue generated from
the sales of various drugs used in the treatment
of SLE that are available in the market. Global
SLE Drugs Market 2015-2019, has been prepared
based on an in-depth market analysis with inputs
from industry experts. The report covers the
Americas, and the APAC and EMEA it covers the
Global SLE Drugs market landscape and its growth
prospects in the coming years. The report
includes a discussion of the key vendors
operating in this market. Key Regions Americas
APAC EMEA
_at_Bigmarketresearch
4
Key Benefits
Description
Key Vendors Anthera Pharmaceuticals BMS
GSK ImmuPharma Merck Serono UCB Other
Prominent Vendors Amgen HGS Immunomedics
Johnson and Johnson MedImmune Sanofi Teva
Pharmaceutical Industries
_at_Bigmarketresearch
5
Description
Market Driver High Prevalence of Autoimmune
Disease For a full, detailed list, view our
report Market Challenge Complex Etiology For
a full, detailed list, view our report Market
Trend Increase in Awareness For a full,
detailed list, view our report Enquire About
Report _at_ http//www.bigmarketresearch.com/report-e
nquiry/222329
_at_Bigmarketresearch
6
Table Of Contents
Table Of Content
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Introduction 06. Disease
Overview 07. SLE Pipeline Landscape 08. Market
Landscape 09. Market Assessment of Benlysta 10.
Market Segmentation by Type 11. Market
Segmentation by Therapeutic Class 12.
Geographical Segmentation 13. Buying Criteria 14.
Market Growth Drivers 15. Drivers and their
Impact 16. Market Challenges 17. Impact of
Drivers and Challenges 18. Market Trends 19.
Trends and their Impact 20. Vendor Landscape 21.
Key Vendor Analysis 22. Other Reports in this
Series
_at_Bigmarketresearch
7
Get Full Information At http//www.bigmarketrese
arch.com/global-systemic-lupus-erythematosus-sle-d
rugs-2015-2019-market